Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01647399 · ClinicalTrials.gov registry record

Vitamin D, Steroids, and Asthma in African American Youth

A clinical trial of Asthma and Allergy, sponsored by Robert J. Freishtat.

Completed
Registry status
273
Enrollment target
1
Study location

NCT01647399: Completed study of Asthma and Allergy, sponsored by Robert J. Freishtat.

NCT01647399 is a study of Asthma and Allergy that has completed, run by Robert J. Freishtat. The registered enrollment target is 273 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01647399, a study of Asthma and Allergy, has completed, sponsored by Robert J. Freishtat.

COMPLETED
Registry status
273 participants
Enrollment target
1
Study location

Study Summary

Asthma has become considerably more prevalent and severe in the U.S. during the last 40 years, particularly affecting youth in urban areas, yet the reasons for this are not clear. There is increasing evidence that vitamin D insufficiency contributes to more severe asthma through increased risk of respiratory infections and decreased sensitivity to glucocorticoids. Indeed, low vitamin D levels are linked with the need for exogenous glucocorticoids and increased asthma severity. Particularly relevant to health disparities, we showed a strong association between vitamin D insufficiency and asthma in urban African American (AA) youth. Importantly, AA youth in ours and other studies had lower vitamin D levels than non-AA participants. Because AA youth residing in urban Washington, DC have markedly worse asthma than other racial/ethnic groups (e.g. prevalence rate 20% higher than the national rate 15 and emergency department utilization rates up to 5 times the national rates and nearly 10 times the Healthy People 2010 target rate), we will utilize our access to this population at the extreme of asthma disparities to examine the contribution of vitamin D to disparities in the chronic control and acute severity of asthma. The overall goal of this study is to provide critical epidemiological/molecular information that will inform the interpretation of ongoing and impending randomized clinical trials of vitamin D supplementation in asthma, especially with regard to urban AA youth with asthma. We hypothesize that low serum 25-hydroxyvitamin D \[25(OH)D\] levels are associated with poor chronic asthma control, worse acute asthma severity, and glucocorticoid insensitivity. The knowledge generated by the experiments in this application will be crucial to translation of this inexpensive, easily-accessible, and thereby potentially disparity-reducing prospective therapy for asthma.

Conditions Studied

Study Locations (1)

District of Columbia

  • Children's National Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 273 participants
Start Date 2012-07
Est. Completion 2018-07
Robert J. Freishtat

1 total trials

What the finished NCT01647399 record still lists

NCT01647399 is an observational study that tracks outcomes without assigning an intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (83% lower).

The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.

NCT01647399 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01647399 about?

NCT01647399 is a clinical study titled "Vitamin D, Steroids, and Asthma in African American Youth". Asthma has become considerably more prevalent and severe in the U.S. during the last 40 years, particularly affecting youth in urban areas, yet the reasons for this are not clear. There is increasing evidence that vitamin D insufficiency contributes to more severe asthma through increased risk of re...

What is the current status of trial NCT01647399?

This trial is currently completed. The enrollment target is 273 participants. The study started on 2012-07. Estimated completion is 2018-07.

What conditions does trial NCT01647399 study?

This clinical trial studies the following conditions: Asthma, Allergy.

Who is sponsoring clinical trial NCT01647399?

This trial is sponsored by Robert J. Freishtat, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01647399 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01647399's enrollment target sits among peer trials

273 135th of 374 higher than 239 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07229430 · 273 participants · NA

    Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

  • NCT03808922 · 274 participants · Phase 3

    Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

  • NCT04573504 · 274 participants · Phase 4

    Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair

  • NCT05289557 · 274 participants · Phase 3

    The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01647399, the US trial registry maintained by the National Library of Medicine. NCT01647399 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.